Lyrica: Advanced Neuropathic Pain Relief
| Product dosage: 150 mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 30 | $1.68 | $50.49 (0%) | 🛒 Add to cart |
| 60 | $1.35 | $100.98 $80.78 (20%) | 🛒 Add to cart |
| 90 | $1.32 | $151.47 $119.16 (21%) | 🛒 Add to cart |
| 120 | $1.30 | $201.96 $155.51 (23%) | 🛒 Add to cart |
| 270 | $1.08
Best per cap | $454.41 $290.82 (36%) | 🛒 Add to cart |
| Product dosage: 75 mg | |||
|---|---|---|---|
| Package (num) | Per cap | Price | Buy |
| 60 | $0.94 | $56.55 (0%) | 🛒 Add to cart |
| 90 | $0.91 | $84.82 $81.79 (4%) | 🛒 Add to cart |
| 120 | $0.86 | $113.10 $103.00 (9%) | 🛒 Add to cart |
| 270 | $0.71
Best per cap | $254.47 $190.85 (25%) | 🛒 Add to cart |
Synonyms | |||
Lyrica (pregabalin) is a prescription medication specifically formulated for the management of neuropathic pain and certain seizure disorders. As a potent anticonvulsant and neuropathic pain agent, it belongs to the class of drugs known as gabapentinoids. It functions by calming overactive nerves in the brain and spinal cord, providing targeted relief for chronic pain conditions. This medication is a cornerstone in the therapeutic strategy for numerous neurological conditions, offering a significant improvement in quality of life for appropriate patients under strict medical supervision.
Features
- Active pharmaceutical ingredient: Pregabalin
- Available in oral capsule formulations: 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, 300 mg
- Also available as an oral solution (20 mg/mL)
- Schedule V controlled substance designation
- Rapid absorption with peak plasma concentrations achieved within 1.5 hours
- High bioavailability (>90%) and linear pharmacokinetics
- Primarily excreted unchanged by the kidneys
- Manufactured under strict cGMP (current Good Manufacturing Practice) standards
Benefits
- Provides significant reduction in the sharp, shooting, and burning pain associated with diabetic peripheral neuropathy and postherpetic neuralgia.
- Effective as adjunctive therapy for managing partial-onset seizures in adults, reducing seizure frequency.
- Offers efficacy in the management of fibromyalgia, improving pain scores, sleep quality, and fatigue.
- Approved for the treatment of neuropathic pain associated with spinal cord injury.
- Can help manage generalized anxiety disorder (GAD) in some regions, though this is not a universal approval.
- Improves overall patient-reported outcomes, including sleep interference and general activity levels, due to effective pain control.
Common use
Lyrica is commonly prescribed for a range of conditions rooted in neurological hyperexcitability. Its primary and most well-established use is for neuropathic pain conditions. This includes diabetic peripheral neuropathy, where nerve damage causes pain in the extremities, and postherpetic neuralgia, the persistent nerve pain following a shingles outbreak (herpes zoster). It is also a FDA-approved medication for managing the widespread pain of fibromyalgia. In neurology, it is used as an add-on (adjunctive) treatment for adults with partial-onset seizures. Furthermore, it is indicated for the management of neuropathic pain associated with spinal cord injury. Off-label, it is sometimes used for other types of chronic pain and generalized anxiety disorder, though such use requires careful consideration by a healthcare provider.
Dosage and direction
Dosage must be individualized based on renal function and therapeutic response. The following are general guidelines; always adhere to the specific prescription provided by a physician.
- Neuropathic Pain (Diabetic Peripheral Neuropathy, Postherpetic Neuralgia): The starting dose is 150 mg per day, administered in two or three divided doses (e.g., 75 mg twice daily or 50 mg three times daily). Based on efficacy and tolerability, the dose may be increased to 300 mg/day within one week. If needed, and if the patient tolerates it, the dose can be further increased to a maximum of 600 mg/day after 2-4 weeks.
- Fibromyalgia: Begin with 150 mg/day in two divided doses (75 mg twice daily). May be increased to 300 mg/day within one week and to 450 mg/day as needed for efficacy.
- Adjunctive Therapy for Seizures: Start with 150 mg/day in two or three divided doses. May be increased to a maximum of 600 mg/day based on response.
- Neuropathic Pain Associated with Spinal Cord Injury: Start with 150 mg/day in two divided doses (75 mg twice daily). May be increased to 300 mg/day within one week. The maximum recommended dose is 600 mg/day.
- Renal Impairment: Dosage must be reduced in patients with compromised renal function (creatinine clearance < 60 mL/min). Please refer to the full prescribing information for specific dosing tables.
- Administration: Can be taken with or without food. Swallow the capsule whole with water. The oral solution should be measured with the provided dosing syringe.
Precautions
- Dizziness and Somnolence: Lyrica may cause significant dizziness and drowsiness, which can impair mental and physical abilities required for tasks such as driving or operating machinery. Patients should be cautioned about these effects, especially at the initiation of therapy and after any dose increase.
- Angioedema: Serious allergic reactions, including angioedema (swelling of the face, mouth, tongue, lips, and throat), have been reported. This requires immediate discontinuation of the drug and emergency medical attention.
- Suicidal Behavior and Ideation: Antiepileptic drugs, including pregabalin, increase the risk of suicidal thoughts or behavior. Patients, their caregivers, and families should be alert to the emergence or worsening of depression, any unusual changes in mood or behavior, or the emergence of suicidal thoughts.
- Respiratory Depression: May occur when used concomitantly with central nervous system (CNS) depressants, especially in patients with underlying respiratory impairment. Use with caution in patients at risk.
- Peripheral Edema: Lyrica can cause peripheral edema (swelling of the extremities). Caution is advised in patients with pre-existing cardiac conditions or those taking thiazolidinedione antidiabetic drugs, which also can cause edema.
- Weight Gain: Significant weight gain has been observed with Lyrica use. Patients should be monitored for this, and it may necessitate discontinuation.
- Blurred Vision and Other Visual Effects: May cause visual disturbances, including blurred vision. A comprehensive eye exam is recommended for patients reporting new or worsening visual symptoms.
- Abrupt Discontinuation: Avoid abruptly stopping Lyrica, as it may lead to insomnia, nausea, headache, anxiety, hyperhidrosis, and diarrhea. Taper the dose gradually over a minimum of one week.
Contraindications
Lyrica is contraindicated in patients with a known hypersensitivity to pregabalin or any of the excipients in the formulation. Hypersensitivity reactions have included cases of angioedema.
Possible side effect
The most common side effects, often dose-related, include:
- Dizziness
- Somnolence (drowsiness)
- Dry mouth
- Peripheral edema
- Blurred vision
- Weight gain
- Difficulty with concentration/attention
- Euphoria
- Balance disorder/ataxia Less common but serious side effects require immediate medical attention and include:
- Signs of angioedema (swelling of the face, mouth, throat)
- Suicidal thoughts or behavior
- Unexplained muscle pain, tenderness, or weakness (could be rhabdomyolysis)
- New or worsening depression, anxiety, panic attacks, insomnia, or irritability
- Severe skin reactions
- Signs of a serious allergic reaction (hives, difficulty breathing)
Drug interaction
- CNS Depressants: Concomitant use with alcohol, opioids, benzodiazepines (e.g., lorazepam, alprazolam), or barbiturates may potentiate the effects of dizziness, somnolence, and respiratory depression.
- Thiazolidinedione Antidiabetic Agents (e.g., pioglitazone, rosiglitazone): Co-administration may increase the risk of peripheral edema and weight gain.
- Angiotensin-Converting Enzyme (ACE) Inhibitors: Concomitant use has been associated with an increased risk of angioedema.
- Oxycodone: Concurrent use may enhance the effects of oxycodone, including euphoria and CNS depression, and may increase levels of pregabalin.
Missed dose
If a dose is missed, it should be taken as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed dose should be skipped. Do not take a double dose to make up for a missed one. Maintaining a consistent dosing schedule is important for stable therapeutic effects.
Overdose
Signs of overdose may include severe drowsiness, sedation, restlessness, agitation, confusion, depression, and seizures. In cases of massive overdose, respiratory depression and coma may occur. There is no specific antidote for pregabalin overdose. Treatment consists of general supportive measures and may include gastric lavage if ingestion was recent. Hemodialysis may be effective in removing pregabalin from the blood and is recommended in cases of severe overdose, especially in patients with renal impairment.
Storage
Store Lyrica capsules and oral solution at room temperature, between 20°C to 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). Keep the bottle tightly closed and away from moisture, light, and heat. Do not store the oral solution after 45 days of first opening the bottle. Keep all medications out of the reach of children and pets.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The author does not recommend or endorse any specific tests, physicians, products, procedures, opinions, or other information that may be mentioned.
Reviews
“After struggling with debilitating neuropathic pain from diabetic neuropathy for years, Lyrica has been a game-changer. The initial drowsiness was significant, but it subsided after two weeks. My pain levels have decreased from an 8/10 to a manageable 2/10, allowing me to sleep through the night and resume daily activities.” – M.B., 62
“As an adjunct for my partial seizures, adding Lyrica to my existing regimen reduced my monthly seizure frequency by approximately 70%. The side effect of weight gain has been challenging to manage, but the trade-off for improved seizure control has been worth it for me under my neurologist’s guidance.” – J.K., 34
“The efficacy for my fibromyalgia pain was remarkable, but I had to discontinue use due to severe peripheral edema and significant blurring of my vision. It’s a powerful medication that works well for many, but the side effect profile requires very close monitoring.” – S.T., 51